SCHEMBL8201787

SCHEMBL8201787

FC(F)(F)c1cc(-c2ccccc2C2=NCCN2)cc(C(F)(F)F)c1

nearest known ligand 0.62

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NISCH Q9Y2I1 16/20 0.62
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8200380 0.89 NISCH (0.63) NISCH
SCHEMBL8189633 0.87 NISCH (0.71) NISCHCYP1A2
Hydrochloric Acid SCHEMBL8200654 0.82 NISCH (0.45) NISCHKDM4ECYP1A2
SCHEMBL8196824 0.80 NISCH (0.76) NISCH
SCHEMBL8197665 0.79 NISCH (0.49) NISCHKDM4ECYP1A2
SCHEMBL9579892 0.79 NISCH (0.81) NISCH
SCHEMBL7738682 0.75 NISCH (0.63) NISCH
SCHEMBL8197935 0.75 NISCH (0.75) NISCH
SCHEMBL8204316 0.75 NISCH (0.74) NISCH
Hydrochloric Acid SCHEMBL8201249 0.73 NISCH (0.44) NISCHKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 WO disclosed